Dell'Osso B - Search Results

1

Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.

Galimberti D, Dell'Osso B, Fenoglio C, Villa C, Cortini F, Serpente M, Kittel-Schneider S, Weigl J, Neuner M, Volkert J, Leonhard C, Olmes DG, Kopf J, Cantoni C, Ridolfi E, Palazzo C, Ghezzi L, Bresolin N, Altamura AC, Scarpini E, Reif A. Galimberti D, et al. PLoS One. 2012;7(4):e32164. doi: 10.1371/journal.pone.0032164. Epub 2012 Apr 10. PLoS One. 2012. PMID: 22505994 Free PMC article.

2

Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series.

Dell'Osso B, Mundo E, Altamura AC. Dell'Osso B, et al. CNS Spectr. 2006 Nov;11(11):879-83; quiz 885. doi: 10.1017/s1092852900015029. CNS Spectr. 2006. PMID: 17075559

3

Diagnosis and treatment of obsessive-compulsive disorder and related disorders.

Dell'Osso B, Altamura AC, Mundo E, Marazziti D, Hollander E. Dell'Osso B, et al. Int J Clin Pract. 2007 Jan;61(1):98-104. doi: 10.1111/j.1742-1241.2006.01167.x. Int J Clin Pract. 2007. PMID: 17229184 Review.

4

Duration of untreated illness in major depressive disorder: a naturalistic study.

Altamura AC, Dell'Osso B, Mundo E, Dell'Osso L. Altamura AC, et al. Int J Clin Pract. 2007 Oct;61(10):1697-700. doi: 10.1111/j.1742-1241.2007.01450.x. Int J Clin Pract. 2007. PMID: 17877655

5

The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.

Bareggi SR, Mundo E, Dell'Osso B, Altamura AC. Bareggi SR, et al. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):741-53. doi: 10.1517/17425255.3.5.741. Expert Opin Drug Metab Toxicol. 2007. PMID: 17916059 Review.

6

Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.

Dell'osso B, Mundo E, Marazziti D, Altamura AC. Dell'osso B, et al. J Psychopharmacol. 2008 Mar;22(2):210-3. doi: 10.1177/0269881107079865. Epub 2008 Jan 21. J Psychopharmacol. 2008. PMID: 18208931

7

May duration of untreated illness influence the long-term course of major depressive disorder?

Altamura AC, Dell'osso B, Vismara S, Mundo E. Altamura AC, et al. Eur Psychiatry. 2008 Mar;23(2):92-6. doi: 10.1016/j.eurpsy.2007.11.004. Epub 2008 Jan 14. Eur Psychiatry. 2008. PMID: 18248964

8

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

Altamura AC, Mundo E, Dell'Osso B, Tacchini G, Buoli M, Calabrese JR. Altamura AC, et al. J Affect Disord. 2008 Sep;110(1-2):135-41. doi: 10.1016/j.jad.2008.01.017. Epub 2008 Mar 10. J Affect Disord. 2008. PMID: 18329720

9

Impulsive-compulsive buying disorder: clinical overview.

Dell'Osso B, Allen A, Altamura AC, Buoli M, Hollander E. Dell'Osso B, et al. Aust N Z J Psychiatry. 2008 Apr;42(4):259-66. doi: 10.1080/00048670701881561. Aust N Z J Psychiatry. 2008. PMID: 18330768 Review.

10

Duration of untreated illness as a predictor of treatment response and clinical course in generalized anxiety disorder.

Altamura AC, Dell'osso B, D'Urso N, Russo M, Fumagalli S, Mundo E. Altamura AC, et al. CNS Spectr. 2008 May;13(5):415-22. doi: 10.1017/s1092852900016588. CNS Spectr. 2008. PMID: 18496479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

324 results

Search Page